Mice with hepatocytes-specific deletion (AlbCre+Cc1fl/fl) or inactivation (L-SACC1) of Ceacam1 provide an in vivo demonstration that hepatic inflammation and fibrosis can be associated with visceral obesity, insulin resistance, and hepatic steatosis. This evidence concerns the gene CEACAM1 and fatty liver disease.